Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-03
2006-01-03
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S304000, C546S097000, C546S124000, C546S125000
Reexamination Certificate
active
06982271
ABSTRACT:
The present invention provides compounds, specifically novel tropane analogs, capable of acting as inhibitors of reuptake of monoamines. In preferred embodiments, these compositions are selective inhibitors of serotonin and/or norepinephrine reuptake. Also provided herein are pharmaceutical compositions comprising novel tropane analogs and a pharmaceutically acceptable carrier, and methods for treating conditions in which inhibition of reuptake of monoamines is desired. The inventive compositions as described herein are also useful for medical therapy and diagnosis.
REFERENCES:
patent: 6150376 (2000-11-01), Kozikowski et al.
patent: WO 92/01688 (1992-02-01), None
patent: WO 97/16451 (1997-05-01), None
Hoepping et al.; “Novel Conformationally Constrained Tropane Analogues by 6-endo-trig Radical Cyclization and Stille Coupling—Switch of Activity Toward the Serotonin and/or Norepinephrine Transporter”, J. Med. Chem. 43: 2064-2071, (2000).
Corey et al.; “A Stereoselective Synthesis of (±)-11-Hydroxy-trans-8-dodecenoic Acid Lactone, a Naturally Occuring Macrolide From Cephalosporium Recifei”, Journal of the American Chemical Society 98(1): 222-224, (Jan. 7, 1976).
Stille and Groh; “Stereospecific Cross-Coupling of Vinyl Halides with Vinyl Tin Reagents Catalyzed by Palladium”, J. Am. Chem. Soc. 109: 813-817, (1987).
Nozaki et al.; “Et3B-Induced Radical Addition of R3SnH to Acetylenes and Its Application to Cyclization Reaction”, J. Am. Chem. Soc. 109: 2547-2549, (1987).
Smith et al.; “Tuning the Selectivity of Monoamine Transporter Inhibitors by the Stereochemistry of the Nitrogen Lone Pair”, J. Am. Chem. Soc. 120: 9072-9073, (1998).
Kilty et al.; “Cloning and Expression of Cocaine-Sensitive Rat Dopamine Transporter”, Science, 254:578-579, (Oct. 25, 1991).
Nelson Nathan; “The Family of Na+/C1—Neurotransmitter Transporters”, Journal of Neurochemistry71: 1785-1803, (1998).
Byrne and Rothschild; “Loss of Antidepressant Efficacy During Maintenance Therapy: Possible Mechanisms and Treatments”, J. Clin. Psychiatry, 59(6): 279-288, (Jun. 1998).
Caroll et al.; “Synthesis, Ligand Binding, and QSAR (CoMFA and Classical) Atudy of 3β-(3' -Substituted Phenyl)-, and 3β-(3', 4' -Disubstituted Phenyl)tropane-2β-Carboxylic Acid Methyl Esters”, J. Med. Chem. 37: 2865-2873, (1994).
Owens et al.; “Neurotranmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites”, The Journal of Pharmacology and Experimental Therapeutics, 283(3): 1305-1322, (1997).
Olofson et al.; “A New Reagent for the Selective, High-Yeild N- Dealkylation of Tertiary Amines: Improved Syntheses of Naltrexone and Nalbuphine”, The Journal of Organic Chemistry 49:2081-2082, (1984).
Lapin and Oxenkurg, Intensification of the Central Seretoninergic Processes as a Possible Determinant of the Thymoleptic Effect, The Lancet, 1: 132-136 (Jan. 18, 1969).
Horst and Preskorn, “Mechanisms of Action and Clinical Characterisitics of Three Atypical Antidepressants: Venlafaxine, Nefazodone, Bupropion”, Journal of Affective Disorders 51: 237-254, (1998).
Schildkraut and J. Joseph; “The Catecholamine Hypothesis of Affective Disorders: A Review of Supporting Evidence”, The American Journal of Psychiatry, 122: 509-522, (1965).
Boyd and Weissman; “Epidemiology of Affective Disorders”, Arch. Gen. Psychiatry, 38:1039-1046 (Sep. 1981).
Broekkamp et al.; “Prospects for Improved Antidepressants”, Journal of Medicinal Chemistry, 38(23): 4615-4633, (Nov. 10, 1995).
International Search Report, mailed on Jul. 27, 2001.
Hoepping Wolfgang Alexander
Kozikowski Alan P.
Foley & Hoag LLP
Georgetown University
Gordon Dana M.
Huang Evelyn Mei
LandOfFree
Tropane analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tropane analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tropane analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3575505